The estimated Net Worth of Nhat H Ngo is at least $6.28 Million dollars as of 19 June 2019. Mr. Ngo owns over 4,948 units of Omnicell stock worth over $1,514,901 and over the last 16 years he sold OMCL stock worth over $3,004,578. In addition, he makes $1,757,290 as Executive Vice President - Marketing and Strategy and Business Development at Omnicell.
Nhat has made over 38 trades of the Omnicell stock since 2009, according to the Form 4 filled with the SEC. Most recently he exercised 4,948 units of OMCL stock worth $213,110 on 19 June 2019.
The largest trade he's ever made was exercising 41,875 units of Omnicell stock on 19 July 2013 worth over $477,375. On average, Nhat trades about 2,278 units every 47 days since 2008. As of 19 June 2019 he still owns at least 35,173 units of Omnicell stock.
You can see the complete history of Mr. Ngo stock trades at the bottom of the page.
Nhat H. Ngo J.D. serves as Executive Vice President - Marketing, Strategy and Business Development of the Company. He joined Omnicell in November 2008 as Vice President of Strategy and Business Development. In March 2012, Mr. Ngo was named Executive Vice President, Strategy and Business Development. In January 2018, Mr. Ngo was named Executive Vice President, Marketing, Strategy and Business Development. From January 2007 to October 2008, Mr. Ngo served as Vice President of Business Development and Licensing for a business unit of Covidien, a global healthcare products company. From June 1999 to April 2006, Mr. Ngo worked at BriteSmile, Inc., a direct-to-consumer aesthetic technology company and served in a variety of senior leadership positions in marketing, sales, operations, strategic planning and corporate development. From September 1997 to June 1999, Mr. Ngo practiced corporate law at Shaw Pittman, LLP. Mr. Ngo received a B.S. in commerce, with a concentration in finance, from the University of Virginia McIntire School of Commerce and a J.D. from the University of Virginia School of Law.
As the Executive Vice President - Marketing and Strategy and Business Development of Omnicell, the total compensation of Nhat Ngo at Omnicell is $1,757,290. There are 4 executives at Omnicell getting paid more, with Randall Lipps having the highest compensation of $7,208,970.
Nhat Ngo is 47, he's been the Executive Vice President - Marketing and Strategy and Business Development of Omnicell since 2018. There are 17 older and 2 younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.
Nhat's mailing address filed with the SEC is C/O OMNICELL, INC., 590 E.MIDDLEFIELD, MOUNTAIN VIEW, CA, 94043.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps, and Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: